25 Stocks Moving in Monday's Pre-Market Session

Gainers

• Society Pass Incorporated SOPA rose 68% to $5.59 in pre-market trading after the company reported addition to the Russell 2000 Index.
• Verso Corporation VRS rose 32% to $26.45 in pre-market trading after the company agreed to be acquired by BillerudKorsnäs AB for $27 per share in cash.
• SeaChange International, Inc. SEAC rose 16.9% to $1.80 in pre-market trading after declining around 8% on Friday. SeaChange recently reported better-than-expected Q3 results.
• GBS Inc. GBS rose 16.7% to $1.47 in pre-market trading after dipping 23% on Friday. GBS recently announced application for FDA breakthrough device designation to fast track rapid saliva glucose test.
• Ocugen, Inc. OCGN rose 13.7% to $5.96 in pre-market trading. Ocugen recently announced that immune response data following two doses of Covaxin from a third-party study were published on the preprint server, medRxiv.
• Alpha Pro Tech, Ltd. APT rose 9.8% to $6.60 in pre-market trading. Alpha Pro Tech recently added $2 million to its buyback program.
• Calliditas Therapeutics AB CALT rose 9.4% to $25.67 in pre-market trading. Calliditas Therapeutics recently announced it was granted by the FDA accelerated approval of TARPEYO to reduce proteinuria in lgA nephropathy.
• Novavax, Inc. NVAX rose 7.7% to $233.97 in pre-market trading. Novavax and Serum Institute of India said the World Health Organization has granted Emergency Use Listing for NVX-CoV2373 COVID-19 vaccine.
• Zosano Pharma Corporation ZSAN rose 7.6% to $0.5485 in pre-market trading after dropping around 5% on Friday. Zosano Pharma recently announced changes to board of directors.
• Allied Healthcare Products, Inc. AHPI rose 6.4% to $6.17 in pre-market trading after gaining around 4% on Friday.
• Sonnet BioTherapeutics Holdings, Inc. SONN shares rose 6.4% to $0.50 in pre-market trading. Sonnet BioTherapeutics, on Friday, disclosed its financial results for the fiscal year ended September 30th, 2021 and provided a business update.

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Check out these big penny stock gainers and losers

Losers

• Spruce Biosciences, Inc. SPRB fell 16.5% to $4.20 in pre-market trading. Spruce Biosciences shares jumped more than 102% on Friday after Oppenheimer initiated coverage on the stock with an Outperform rating and a $15 price target.
• Bellerophon Therapeutics, Inc. BLPH fell 16.3% to $2.67 in pre-market trading. Bellerophon Therapeutics jumped around 35% on Friday after topline data from Phase 2 study (PULSE-PHPF-002) evaluating the acute hemodynamic benefit of INOpulse via right heart catheterization for pulmonary hypertension associated with sarcoidosis (PH-Sarc)..
• Immix Biopharma, Inc. IMMX fell 15% to $3.40 in pre-market trading amid post-IPO volatility.
• Iris Energy Limited IREN fell 12.2% to $15.55 in pre-market trading after climbing 26% on Friday.
• Avinger, Inc. AVGR shares fell 11.9% to $0.4670 in pre-market trading. Avinger, last month, announced FDA clearance of pantheris for the treatment of in-stent restenosis.
• Argo Blockchain plc ARBK fell 9.4% to $11.75 in pre-market trading after rising around 5% on Friday.
• Arqit Quantum Inc. ARQQ shares fell 9.3% to $18.06 in pre-market trading after jumping 22% on Friday.
• cbdMD, Inc. YCBD shares fell 9% to $1.21 in pre-market trading. cbdMD reported FY21 net sales of $44.5 million, versus $41.8 million in FY20.
• Eloxx Pharmaceuticals, Inc. ELOX shares fell 8.8% to $0.6737 in pre-market trading. Eloxx Pharmaceuticals shares climbed 12% on Friday after Oppenheimer initiated coverage on the stock with an Outperform rating and a $4 price target.
• Arbutus Biopharma Corporation ABUS shares fell 8.2% to $3.93 in pre-market trading following a 10% surge on Friday.
• Zhihu Inc. ZH shares fell 8.2% to $5.25 in pre-market trading.
• Turkcell Iletisim Hizmetleri A.S. TKC fell 7.7% to $3.11 in pre-market trading after declining around 6% on Friday.
• Laredo Petroleum, Inc. LPI fell 6.9% to $54.90 in pre-market trading.
• Catalyst Biosciences, Inc. CBIO fell 6% to $0.9494 in pre-market trading.